Your browser doesn't support javascript.
loading
A benchmark for neural network robustness in skin cancer classification.
Maron, Roman C; Schlager, Justin G; Haggenmüller, Sarah; von Kalle, Christof; Utikal, Jochen S; Meier, Friedegund; Gellrich, Frank F; Hobelsberger, Sarah; Hauschild, Axel; French, Lars; Heinzerling, Lucie; Schlaak, Max; Ghoreschi, Kamran; Hilke, Franz J; Poch, Gabriela; Heppt, Markus V; Berking, Carola; Haferkamp, Sebastian; Sondermann, Wiebke; Schadendorf, Dirk; Schilling, Bastian; Goebeler, Matthias; Krieghoff-Henning, Eva; Hekler, Achim; Fröhling, Stefan; Lipka, Daniel B; Kather, Jakob N; Brinker, Titus J.
Afiliação
  • Maron RC; Digital Biomarkers for Oncology Group, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Schlager JG; Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.
  • Haggenmüller S; Digital Biomarkers for Oncology Group, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • von Kalle C; Department of Clinical-Translational Sciences, Charité University Medicine and Berlin Institute of Health (BIH), Berlin, Germany.
  • Utikal JS; Department of Dermatology, Heidelberg University, Mannheim, Germany; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Meier F; Skin Cancer Center at the University Cancer Centre and National Center for Tumor Diseases Dresden, Department of Dermatology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Gellrich FF; Skin Cancer Center at the University Cancer Centre and National Center for Tumor Diseases Dresden, Department of Dermatology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Hobelsberger S; Skin Cancer Center at the University Cancer Centre and National Center for Tumor Diseases Dresden, Department of Dermatology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Hauschild A; Department of Dermatology, University Hospital of Kiel, Kiel, Germany.
  • French L; Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.
  • Heinzerling L; Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.
  • Schlaak M; Charité - Universitätsmedizin Berlin, Department of Dermatology, Venereology and Allergology, Berlin, Germany.
  • Ghoreschi K; Charité - Universitätsmedizin Berlin, Department of Dermatology, Venereology and Allergology, Berlin, Germany.
  • Hilke FJ; Charité - Universitätsmedizin Berlin, Department of Dermatology, Venereology and Allergology, Berlin, Germany.
  • Poch G; Charité - Universitätsmedizin Berlin, Department of Dermatology, Venereology and Allergology, Berlin, Germany.
  • Heppt MV; Department of Dermatology, University Hospital Erlangen, Erlangen, Germany.
  • Berking C; Department of Dermatology, University Hospital Erlangen, Erlangen, Germany.
  • Haferkamp S; Department of Dermatology, University Hospital Regensburg, Regensburg, Germany.
  • Sondermann W; Department of Dermatology, University Hospital Essen, Essen, Germany.
  • Schadendorf D; Department of Dermatology, University Hospital Essen, Essen, Germany.
  • Schilling B; Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.
  • Goebeler M; Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.
  • Krieghoff-Henning E; Digital Biomarkers for Oncology Group, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hekler A; Digital Biomarkers for Oncology Group, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Fröhling S; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ) & National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Lipka DB; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ) & National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Kather JN; Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
  • Brinker TJ; Digital Biomarkers for Oncology Group, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: titus.brinker@dkfz.de.
Eur J Cancer ; 155: 191-199, 2021 09.
Article em En | MEDLINE | ID: mdl-34388516
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Redes Neurais de Computação / Benchmarking Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Redes Neurais de Computação / Benchmarking Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha